Inspyr Therapeutics, Inc. announced that Christopher Lowe has been appointed as President and Chief Executive Officer, and as a member of the company's Board of Directors. He brings to the company more than 15 years of executive management experience in life sciences as Chief Executive Officer, Chief Financial Officer and Chief Business Officer, and has been an advisor to the company's board of directors since March 2016. He previously was interim CEO and CFO of Hansen Medical, and CFO and Chief Business Officer of Anthera Pharmaceuticals.